Last updated on February 2010
Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation
Brief description of study
Assessing the impact of J12 curative treatment with rituximab (375 mg / m² on J5) based on a composite "TREATMENT FAILURE"
Clinical Study Identifier: NCT01066689
Start Over
Connect »
